cas 1250943-13-5|| where to buy 2-chloro-3-cyclobutoxypyrazine

Nombre del producto:2-chloro-3-cyclobutoxypyrazine

IUPAC Name:2-chloro-3-cyclobutoxypyrazine

Unidad de embalaje	Stock disponible	Precio($)
CM463904-250mg	3-4 Weeks	ĽźŢ
CM463904-500mg	3-4 Weeks	ȎǯȎ
CM463904-1g	3-4 Weeks	ưźȀ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1250943-13-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1250943-13-5; Fórmula molecular:C8H9ClN2O; Punto de fusión:-; Código de sonrisas:ClC1=C(OC2CCC2)N=CC=N1; Densidad:

: Número de catálogo:CM463904; Peso molecular:184.62; Punto de ebullición:; Nº Mdl:MFCD16684464; Almacenamiento:

: Pyrazines; Pyrazine is a heterocyclic aromatic organic compound with chemical formula C4H4N2. The marketed pyrazine drugs are mainly distributed in the field of anti-tumor and anti-infection. In recent years, there have been many new drugs in various fields, and there are some new target drugs worthy of attention.; pyrazine,pyrazine price; if you want to know the latest news about pyrazine and pyrazine price, please come to our website and get a quote for free.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.